ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock Analyst Earnings Estimates
NASDAQ:ARCT - Nasdaq - US03969T1097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.4M 30.53% | 206M 1,561.29% | 166.799M -19.03% | 177.71M 6.54% | 178.24M 0.30% | 326.2M 83.01% | 514.75M 57.80% | 774.91M 50.54% | 1.007B 29.95% | 1.202B 19.36% | 1.39B 15.64% | 1.42B 2.16% | |
| EBITDA YoY % growth | -201.71M -185.63% | 13.73M 106.81% | -75.248M -648.06% | -96.781M -28.62% | -141.238M -45.94% | -183.368M -29.83% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -202.9M -183.78% | 12.2M 106.01% | -78.205M -741.02% | -81.326M -3.99% | -73.948M 9.07% | 19.567M 126.46% | 223.36M 1,041.51% | 503.66M 125.49% | 716.66M 42.29% | 1.218B 69.96% | 1.37B 12.48% | 1.505B 9.85% | |
| Operating Margin | -1,636.29% | 5.92% | -46.89% | -45.76% | -41.49% | 6.00% | 43.39% | 65.00% | 71.17% | 101.33% | 98.56% | 105.99% | |
| EPS YoY % growth | -7.74 -128.32% | 0.34 104.39% | -1.04 -405.88% | -2.48 -189.42% | -2.19 27.16% | 0.34 115.49% | 3.60 961.05% | 8.41 133.32% | 13.21 57.06% | 15.74 19.14% | 19.82 25.95% | 18.70 -5.63% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 45.81% | -0.16 74.70% | -0.70 -170.69% | -0.40 64.39% | 0.86 258.12% | 0.82 607.09% | 2.42 443.48% | 3.15 896.13% |
| Revenue Q2Q % growth | 57.359M 50.90% | 72.733M 45.88% | 64.499M 54.77% | 72.057M 216.46% | 122.72M 113.95% | 126.44M 73.84% | 194.73M 201.91% | 234.91M 226.01% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.585M 48.75% | -6.113M 71.06% | -6.736M 37.27% | -97.41K 99.45% | 73.197M 569.66% | 77.162M 1,362.24% | 104M 1,643.98% | 158.6M 162,916.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -1.11 -246.88% | -0.56 | -0.55 | -98.22% |
| Q3 2024 Q2Q % growth | -0.26 57.38% | -1.24 | 0.98 | 79.04% |
| Q2 2024 Q2Q % growth | -0.64 67.68% | -1.63 | 0.99 | 60.74% |
| Q1 2024 Q2Q % growth | -1.00 -153.48% | -1.21 | 0.21 | 17.53% |
| Q4 2023 Q2Q % growth | -0.32 -107.22% | -1.01 | 0.69 | 68.38% |
| Q3 2023 Q2Q % growth | -0.61 54.14% | -1.73 | 1.12 | 64.65% |
| Q2 2023 Q2Q % growth | -1.98 -141.46% | -0.21 | -1.77 | -821.08% |
| Q1 2023 Q2Q % growth | 1.87 196.39% | 0.06 | 1.81 | 2,968.34% |
| Q4 2022 Q2Q % growth | 4.43 401.36% | 1.00 | 3.43 | 343.79% |
| Q3 2022 Q2Q % growth | -1.33 35.12% | -1.85 | 0.52 | 28.13% |
| Q2 2022 Q2Q % growth | -0.82 60.39% | -1.94 | 1.12 | 57.69% |
| Q1 2022 Q2Q % growth | -1.94 9.77% | -1.47 | -0.47 | -32.29% |
| Q4 2021 Q2Q % growth | -1.47 -17.60% | -1.76 | 0.29 | 16.39% |
| Q3 2021 Q2Q % growth | -2.05 -122.83% | -1.62 | -0.43 | -26.20% |
| Q2 2021 Q2Q % growth | -2.07 -276.36% | -2.19 | 0.12 | 5.51% |
| Q1 2021 Q2Q % growth | -2.15 -220.90% | -1.28 | -0.87 | -68.19% |
| Q4 2020 Q2Q % growth | -1.25 -64.47% | -0.90 | -0.35 | -39.25% |
| Q3 2020 Q2Q % growth | -0.92 -64.29% | -0.50 | -0.42 | -85.11% |
| Q2 2020 Q2Q % growth | -0.55 -685.71% | -0.56 | 0.01 | 2.35% |
| Q1 2020 Q2Q % growth | -0.67 -3.08% | -0.62 | -0.05 | -8.19% |
| Q4 2019 Q2Q % growth | -0.76 | -0.54 | -0.22 | -39.83% |
| Q3 2019 Q2Q % growth | -0.56 | -0.37 | -0.19 | -51.66% |
| Q2 2019 Q2Q % growth | -0.07 | -0.65 | 0.58 | 89.19% |
| Q1 2019 Q2Q % growth | -0.65 | -0.59 | -0.06 | -10.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 22.77M -33.01% | 45.543M | -22.773M | -50.00% |
| Q3 2024 Q2Q % growth | 41.673M -7.68% | 37.329M | 4.344M | 11.64% |
| Q2 2024 Q2Q % growth | 49.859M 373.99% | 22.13M | 27.729M | 125.30% |
| Q1 2024 Q2Q % growth | 38.012M -52.32% | 17.895M | 20.117M | 112.42% |
| Q4 2023 Q2Q % growth | 33.989M -78.80% | 38.613M | -4.624M | -11.98% |
| Q3 2023 Q2Q % growth | 45.14M 236.87% | 16.182M | 28.958M | 178.95% |
| Q2 2023 Q2Q % growth | 10.519M -61.18% | 49.472M | -38.953M | -78.74% |
| Q1 2023 Q2Q % growth | 79.729M 1,433.25% | 38.694M | 41.035M | 106.05% |
| Q4 2022 Q2Q % growth | 160.3M 2,663.79% | 74.137M | 86.163M | 116.22% |
| Q3 2022 Q2Q % growth | 13.4M 458.33% | 3.492M | 9.908M | 283.73% |
| Q2 2022 Q2Q % growth | 27.1M 1,255.00% | 2.131M | 24.969M | 1,171.70% |
| Q1 2022 Q2Q % growth | 5.2M 147.62% | 6.423M | -1.223M | -19.04% |
| Q4 2021 Q2Q % growth | 5.8M 163.64% | 15.01M | -9.21M | -61.36% |
| Q3 2021 Q2Q % growth | 2.4M 4.35% | 22.191M | -19.791M | -89.18% |
| Q2 2021 Q2Q % growth | 2M -13.04% | 2.362M | -362K | -15.33% |
| Q1 2021 Q2Q % growth | 2.1M -19.23% | 2.59M | -490K | -18.92% |
| Q4 2020 Q2Q % growth | 2.2M -26.67% | 2.405M | -205K | -8.52% |
| Q3 2020 Q2Q % growth | 2.3M -30.30% | 3.064M | -764K | -24.93% |
| Q2 2020 Q2Q % growth | 2.3M -77.45% | 3.61M | -1.31M | -36.29% |
| Q1 2020 Q2Q % growth | 2.6M -40.91% | 5.069M | -2.469M | -48.71% |
| Q4 2019 Q2Q % growth | 3M | 3.722M | -722K | -19.40% |
| Q3 2019 Q2Q % growth | 3.3M | 6.014M | -2.714M | -45.13% |
| Q2 2019 Q2Q % growth | 10.2M | 3.428M | 6.772M | 197.55% |
| Q1 2019 Q2Q % growth | 4.4M | 3.13M | 1.27M | 40.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.81% | -1.24% | 8.84% |
| Revenue | -0.01% | -2.78% | 0% | -0.35% |